We are live on ! Find out more
CRVO icon

CervoMed

12 hedge funds and large institutions have $1.25M invested in CervoMed in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

0.13% less ownership

Funds ownership: 0.32%0.19% (-0.13%)

14% less funds holding

Funds holding: 1412 (-2)

46% less capital invested

Capital invested by funds: $2.32M → $1.25M (-$1.07M)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
2
Increased
2
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change

CRVO Hedge Fund Activity: Q3 2019 in Review

12 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q3 2019, worth a combined $1.25M — down 46% from $2.32M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of CRVO and 2 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Vanguard Group, adding an estimated $72.5K. The largest seller was Wells Fargo, exiting entirely with an estimated $427K sold.

  • 12 institutional investors held CervoMed (CRVO) as of Q3 2019, down from 14 in Q2 2019.
  • Funds reported $1.25M of CervoMed stock for Q3 2019, down 46% quarter-over-quarter.
  • 2 funds opened new CervoMed positions in Q3 2019 and 4 closed out, a net change of -2 holders.
  • The largest CervoMed buyer in Q3 2019 was Vanguard Group, an estimated $72.5K added.
  • The largest CervoMed seller in Q3 2019 was Wells Fargo, an estimated $427K sold.

Based on aggregated 13F filings for Q3 2019.